Stephen H. Barnes, the Chief Financial Officer of Accolade, Inc. (NASDAQ:ACCD), recently reported a transaction involving the sale of company shares. On October 17, Barnes sold 122 shares of Accolade's common stock at a price of $3.669 per share, amounting to a total value of $447. This sale was conducted to cover tax withholding obligations related to the vesting and settlement of Restricted Stock Units (RSUs), as indicated in the filing. Following this transaction, Barnes holds 203,341 shares in the company.
Additionally, on October 16, Barnes acquired 415 shares of common stock through the conversion of RSUs. These transactions reflect routine stock management activities by the CFO and are part of his compensation package.
In other recent news, Accolade Inc. has been making headlines for its robust financial results and strategic developments. The healthcare solutions provider reported strong second-quarter results for 2025, exceeding revenue expectations with a total of $106.4 million and surpassing its adjusted EBITDA guidance. Furthermore, Accolade confirmed its fiscal year 2025 revenue guidance between $460 million to $475 million and projected a positive adjusted EBITDA of $15 million to $20 million.
Several analyst firms including Wells Fargo, Stephens, Canaccord Genuity, Truist Securities, and BofA Securities have adjusted their price targets for Accolade, albeit maintaining their ratings. Wells Fargo revised the price target downwards to $6.00 due to concerns over delayed deal closures impacting the company's anticipated growth. In contrast, Stephens and Canaccord Genuity expressed confidence in Accolade's ability to meet performance guarantees and secure new business.
Accolade's management has shown optimism about a strong pipeline with diversification across employers, health plans, and government segments. Despite anticipating slower revenue growth in fiscal year 2026 due to staggered launches, the company's competitive edge in the expert medical opinion product market and successful management of marketing expenses have been notable developments. These recent developments highlight the ongoing strategic and financial evolution of Accolade Inc.
InvestingPro Insights
While Stephen H. Barnes' recent stock transactions reflect routine management activities, Accolade's financial landscape presents a more complex picture. According to InvestingPro data, Accolade's market capitalization stands at $289.13 million, with a revenue of $441.03 million for the last twelve months as of Q2 2025. The company has shown a revenue growth of 16.04% over the same period, indicating some positive momentum.
However, InvestingPro Tips reveal that Accolade is not currently profitable, with analysts not anticipating profitability this year. This aligns with the reported operating income of -$93.68 million and an EBITDA of -$53.62 million for the last twelve months. The company's stock price has also taken a significant hit, with a -60.96% total return over the past six months.
On a more positive note, Accolade operates with a moderate level of debt, and its liquid assets exceed short-term obligations, suggesting a stable short-term financial position. The stock is currently trading near its 52-week low, which could present an opportunity for investors who believe in the company's long-term potential.
These insights are just a sample of the valuable information available through InvestingPro. The platform offers 10 additional tips for Accolade, providing a more comprehensive analysis for investors looking to make informed decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.